drugset / Trial / NCT01019681

Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia

NCT01019681

Phase 1 Terminated 1 enrolled Richard Burt, MD
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether treatment with umbilical cord blood stem cells will improve blood flow to the most severely affected leg of a participant with medically refractory and non-surgical peripheral vascular disease of the lower extremity.

Timeline

Start
2009-11
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cord blood stem cells Cell therapy 1e+07 cells/kg Intramuscular

Indications